Tirzepatide is a dual incretin peptide that activates both GIP and GLP-1 receptors, offering a unique approach to metabolic regulation. By enhancing insulin secretion and reducing appetite, it supports improved energy balance and glucose control. It’s now widely studied in research for its potential benefits in type 2 diabetes, significant weight loss, improved insulin sensitivity, and long-term metabolic health.
For a full scientific overview of Tirzepatide in Canada, see our research reference page:
Tirzepatide — Overview
Bulk orders automatically save 20% on any 10+ vials (BAC excluded)
Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.